Jun 23,2021: AstraZeneca Plc’s Covid-19 vaccine is effective against the highly transmissible Delta Covid-19 variant, first identified in India, an official from the company said on Tuesday. The drug’s efficacy against Kappa, another variant found in India, has also been proven, the official said.
A study by Oxford University investigated the ability of monoclonal antibodies in Sera from recovered people and from vaccinated people to neutralize the Delta and Kappa variants, a statement from the company said.
Drugmakers across the world are rushing to test the efficacy of drugs against the emerging variants of Covid-19 which are proving to be deadlier than the first strain of virus found to have infected humans.
An analysis by the Public Health England (PHE) showed that vaccines made by Pfizer Inc and AstraZeneca offer high protection of more than 90% against hospitalization from the Delta variant.
The latest Oxford study results are built on the recent analysis by PHE, the company said.
The Delta variant is becoming the globally dominant version of the disease, the World Health Organization’s chief scientist said on Friday.
